三孚新科(688359) - 2024 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2024 was ¥133,742,849.43, representing a year-on-year increase of 13.02%[2] - The net profit attributable to shareholders was a loss of ¥11,083,177.56, with a cumulative loss of ¥16,954,200.80 for the year-to-date[2] - Total operating revenue for the first three quarters of 2024 reached CNY 429.93 million, a 29.4% increase from CNY 332.26 million in the same period of 2023[14] - The net loss for the first three quarters of 2024 was CNY 6.66 million, compared to a net loss of CNY 37.78 million in the same period of 2023, showing significant improvement[15] - The total equity attributable to shareholders of the parent company decreased slightly to CNY 479.30 million from CNY 483.90 million in the previous year[13] - Basic and diluted earnings per share for the first three quarters of 2024 were both -CNY 0.18, compared to -CNY 0.35 in the same period of 2023[15] - The company reported a gross profit margin of approximately 40.0% for the first three quarters of 2024, compared to 28.0% in the same period of 2023[14] Research and Development - Research and development (R&D) expenses totaled ¥16,569,410.02 for the quarter, an increase of 31.44% compared to the same period last year, and accounted for 12.39% of operating revenue[3] - The company plans to continue expanding its R&D capabilities and has increased the recruitment of high-education R&D personnel, which has led to higher salary expenses[6] - Research and development expenses increased to CNY 21,470,125.52, up 15.1% from CNY 18,592,886.38 in the previous year[23] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,276,392,248.66, reflecting a 5.40% increase from the end of the previous year[3] - Current assets amounted to CNY 650,875,196.50, up from CNY 543,120,619.77, indicating a growth of about 19.93%[11] - Total liabilities increased to CNY 650,875,196.50, compared to CNY 543,120,619.77, indicating a growth of approximately 19.93%[12] - The company's total liabilities increased to CNY 665.67 million, up from CNY 602.78 million year-on-year[13] - The total assets of the company reached CNY 1.28 billion, an increase from CNY 1.21 billion year-on-year[13] - The total assets of the company as of the end of Q3 2024 were CNY 948,206,266.77, an increase of 7.2% from CNY 884,716,722.27 at the end of Q3 2023[22] - The total liabilities increased to CNY 466,156,021.46, up 21.3% from CNY 384,378,159.74 in the same period last year[22] Cash Flow - The company reported a net cash flow from operating activities of -¥48,005,786.04 year-to-date, indicating cash outflows primarily due to increased payments for goods and taxes[3] - The cash inflow from operating activities for the first three quarters of 2024 was CNY 342,284,899.72, an increase of 29.6% compared to CNY 264,199,689.22 in the same period of 2023[17] - The net cash flow from operating activities was -CNY 48,005,786.04, worsening from -CNY 20,979,750.89 year-over-year[17] - The total cash inflow from investment activities was CNY 26,172,920.55, significantly higher than CNY 2,165,611.05 in the previous year[18] - The net cash flow from investment activities was -CNY 36,941,656.50, an improvement from -CNY 81,295,293.87 in the same period last year[18] - The cash inflow from financing activities reached CNY 356,439,027.72, compared to CNY 231,118,911.74 in the previous year, marking a 54.3% increase[18] - The net cash flow from financing activities was CNY 99,762,420.00, slightly down from CNY 100,037,022.47 year-over-year[18] Market Strategy - The company plans to focus on expanding its market presence and enhancing product development in the upcoming quarters[16] - The company has plans for market expansion and new product development, focusing on enhancing its competitive edge in the new materials sector[23]